Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of centrally acting drugs. Its structural features allow for selective interactions with biological targets, making it valuable in the production of active pharmaceutical ingredients (APIs) for neurological and psychiatric disorders. Commonly employed in the preparation of serotonin and dopamine modulators due to its ability to mimic natural neurotransmitter scaffolds. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies, enabling optimization of potency, selectivity, and metabolic stability in drug candidates.